Gene Therapy Global Market Opportunities And Strategies To 2032

Gene Therapy Market 2023 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 | Pages : 305 | Published : May 2023 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying
Gene Therapy Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gene Therapy Market Definition

Gene therapy is a medical technique that involves introducing or modifying genes within an individual's cells to treat or prevent disease. It aims to correct or replace faulty genes responsible for disease development, restore or enhance the function of normal genes, or introduce new genes to produce therapeutic proteins that can fight or prevent diseases.

The gene therapy market consists of sales, by entities (organizations, sole traders and partnerships), of gene therapy products that are used to treat and prevent disease. It works by introducing an engineered gene into the cells of the patient.  Gene therapy products are biological products.

Gene Therapy Market Size

The global gene therapy market reached a value of nearly $7,370.8 million in 2022, having increased at a compound annual growth rate (CAGR) of 15.8% since 2017. The market is expected to grow from $7,370.8 million in 2022 to $24,027.1 million in 2027 at a rate of 26.7%. The market is then expected to grow at a CAGR of 13.4% from 2027 and reach $45,071.9 million in 2032.  

Growth in the historic period resulted from rising pharmaceutical R&D expenditure, a rise in public-private partnerships, government investments and rising cases of spinal muscular atrophy. Factors that negatively affected growth in the historic period were off-target specificity, challenges in nucleotide delivery to cells, instability of the nucleotides, challenges due to regulatory changes, low healthcare access, reimbursement challenges and the coronavirus pandemic.

Going forward, an increasing number of cancer cases, a growing aging population, increasing research and development spending in the pharmaceutical sector and a rising focus on gene therapy will drive the market. Factors that could hinder the growth of the gene therapy market in the future include high cost of gene therapy, stringent regulations and the Russia- Ukraine war.

Gene Therapy Market Drivers

The key drivers of the gene therapy market include:

Increasing Number Cancer Cases

Increasing number of cancer cases is expected to drive the growth of the gene therapy market during the forecast period. Cancer gene therapy is an emerging field using genetic material to modify cells in vitro or in vivo to help effect a cure. In gene therapy, a therapeutic human-designed new gene (transgene) was used to introduce to a subpopulation of human cells, such as human stem cells. For a cancer cell, the transgene can assist cell death or restore normal cellular functions, whereas for normal cells the transgene can protect them from drug-induced side effects and/or cytotoxicity.  For example, according to the American Cancer Society, a US-based voluntary health organization, a total of 1.9 million new cancer cases and 609,360 deaths from cancer were expected to occur in the USA in 2022, which is about 1,670 deaths a day.  Additionally, according to the International Agency for Research on Cancer, a France-based intergovernmental agency, by 2040, the number of new cancer cases per year globally is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million.  Therefore, the increase in the number of cases of cancer is expected to contribute to the growth of the gene therapy market going forward.

Gene Therapy Market Restraints

The key restraints on the gene therapy market include:

High Cost Of Gene Therapy

High cost of gene therapy is expected to limit the growth of the gene therapy market during the forecast period. The manufacturing and drug development costs have a big impact on the price tags of gene therapy. Depending on the disease, raw materials used in gene therapy can be expensive.  In less wealthy countries, the lack of cost-effective therapies for cancer and other diseases has influenced the health conditions of the population and led to a low average life expectancy. For example, Skysona, a treatment for a rare neurological disorder, launched at $3 million in September 2022. Additionally, in August 2022, Zynteglo, a gene therapy for a genetic blood disorder launched at $2.8 million.  Therefore, the high cost of gene therapy will restrict the growth of the gene therapy market.

Gene Therapy Market Trends

Major trends influencing the gene therapy market include:

Growing Investments and Manufacturing Facility Expansion

Gene therapy manufacturers are progressively investing in the launch of new manufacturing facilities and product portfolio expansion to meet the increasing demand for gene therapies and related products. For example, in June 2022, REGENXBIO, a US based clinical-stage biotechnology company, announced the opening of its new manufacturing innovation center for gene therapy manufacturing in Rockville, Md. The company has invested $65 million to enable end-to-end control of gene therapy manufacturing at the center.  Further, in September 2021, Viralgen, a Bayer-owned CDMO, spent upwards of €50 million ($ 55 million) to expand its capacity for gene therapy manufacturing services at its Miramon Technology Park site in San Sebastian, Spain. The commercial facility will have nine cleanrooms, each with a batch capacity of up to 2,000 L. Viralgen claims that this has expanded its existing viral vector capacity 15-fold, helping to meet the demand for gene therapy production.

Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology

Companies in the market are increasingly focusing on Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to improve gene therapy production. TESSA technology is a plasmid-free, scalable AAV (adeno-associated virus) manufacturing system. TESSA vectors are adenoviral vectors engineered such that they still provide high-quality help for AAV production but cannot produce adenoviral structural proteins, and eliminates contamination.  For example, in March 2022, WuXi AppTec’s wholly-owned subsidiary WuXi Advanced Therapies (WuXi ATU), a US-based integrated contract testing development and manufacturing organization, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to improve scalability and accessibility of cell and gene therapies. The new technology, which is developed by Oxgene, a UK-based biotechnology company offers a scalable process to manufacture gene therapies. It also helps to accelerate the production of therapeutic DNA required for the treatment of patients in need. The technology will expedite the manufacturing of adeno-associated virus (AAV) and reduce the costs to produce cell and gene therapies and they will allow its global customers to develop and deliver accessible therapies for patients as quickly as possible.

Opportunities And Recommendations In The Gene Therapy Market

Opportunities –The top opportunities in the gene therapy market by vector will arise in the viral vector market, which will gain $14,868.9 million of global annual sales by 2027. The top opportunities in the gene therapy market by application will arise in the oncology market, which will gain $7,080.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by end users will arise in the biopharmaceutical companies market, which will gain $8,883.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by gene therapy will arise in the somatic cell therapy market, which will gain $15,839.6 million of global annual sales by 2027. The gene therapy market size will gain the most in the USA at $4,612.0 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the gene therapy companies to  focus on investments in manufacturing facility expansion, focus on use of tetracycline-enabled self-silencing adenovirus (TESSA) technology, increase focus on gene editing, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, focus on mergers and acquisitions, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users , and focus on fast-growing applications.

Gene Therapy Market Segmentation

The gene therapy market is segmented by gene therapy type, by vector, by end users and by application.
By Gene Therapy Type -
The gene therapy market is segmented by gene therapy type into
    • a) Germline Therapy
    • b) Somatic Cell Therapy
The somatic cell therapy was the largest segment of the gene therapy market by gene therapy type, accounting for $7,002.2 million or 95.0% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.
By Vector -
The gene therapy market is segmented by vector into
    • a) Viral Vector
    • b) Non-Viral Vector
The viral vector was the largest segment of the gene therapy market by vector, accounting for $6,555.7 million or 88.9% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.
By End Users -
The gene therapy market is segmented by end users into
    • a) Biopharmaceutical Companies
    • b) Research Institutes
    • c) Other End Users
The biopharmaceutical companies was the largest segment of the gene therapy market by end users, accounting for $3,882.7 million or 52.7% of the total market in 2022. The other end users market is expected to be the fastest-growing segment going forward at a CAGR of 27.6%.
By Application -
The gene therapy market is segmented by application into
    • a) Oncology
    • b) Orphan Disease
    • c) Knee Osteoarthritis
    • d) Neurological Disorders
The oncology market was the largest segment of the gene therapy market by application, accounting for $3,258.2 million or 44.2% of the total market in 2022. The neurological disorders market is expected to be the fastest-growing segment going forward at a CAGR of 27.7%.
By Geography - The gene therapy market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the gene therapy market, accounting for 44.6% of the global market in 2022. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the gene therapy market will be South America and the Middle East, where growth will be at CAGRs of 44.4% and 42.3% respectively from 2022-2027.

Gene Therapy Market Competitive Landscape

Major Competitors are:

  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.

    • Other Competitors Include:

  • UniQure NV
  • REGENXBIO Inc.
  • Bristol-Myers Squibb
  • BioMarin Pharmaceuticals Inc.
  • Jazz Pharmaceuticals Inc.
  • Biocon
  • Cipla
  • EdiGene Inc
  • Takara Bio
  • Daiichi Sankyo Company
  • Mitsubishi Tanabe Pharma
  • Merck
  • GE Healthcare
  • Lonza
  • Pfizer
  • Cellular Biomedicine Group
  • GenScript
  • Albumedix Ltd
  • Catalent
  • Freeline Therapeutics
  • DiNAQOR AG
  • Vivet Therapeutics
  • Allergan
  • Takeda Pharmaceutical
  • Amgen
  • Biocad
  • Celgene Corporation
  • Johnson & Johnson
  • Eli Lilly and Company
  • AstraZeneca
  • Bayer AG
  • Juno Therapeutics
  • Allogene Therapeutics
  • Bluebird Bio
  • Regen BioPharma
  • Bellicum
  • Amgen Brasil
  • GlaxoSmithKline plc
  • Biogen Brazil
  • Biotchpharma
  • BrainStorm Cell Therapeutics
  • Pluristem
  • Sanofi
  • Bayer East Africa Ltd

      • Table Of Contents

      1. Executive Summary

      2. Table Of Contents

      3. List Of Figures

      4. List Of Tables

      5. Report Structure

      6. Introduction And Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Gene Therapy Market Definition And Segmentations

      6.4. Market Segmentation By Gene Therapy Type

      6.4.1. Germline Therapy

      6.4.2. Somatic Cell Therapy

      6.5. Market Segmentation By Vector

      6.5.1. Viral Vector

      6.5.2. Non-Viral Vector

      6.6. Market Segmentation By End Users

      6.6.1. Biopharmaceutical Companies

      6.6.2. Research Institutes

      6.6.3. Other End Users

      6.7. Market Segmentation By Application

      6.7.1. Oncology

      6.7.2. Orphan Disease

      6.7.3. Knee Osteoarthritis

      6.7.4. Neurological Disorders

      7. Major Market Trends

      7.1. Growing Investments and Manufacturing Facility Expansion

      7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology

      7.3. Launch Of Cell And Gene Therapy Platforms

      7.4. Partnerships And Collaborations

      7.5. Rising Focus On Gene Editing

      7.6. Strategic Mergers And Acquisitions

      8. Global Market Size and Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

      8.2.1. Market Drivers 2017 – 2022

      8.2.2. Market Restraints 2017 – 2022

      8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      8.3.1. Market Drivers 2022 – 2027

      8.3.2. Market Restraints 2022 – 2027

      9. Global Gene Therapy Market Segmentation

      9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10. Gene Therapy Market, Regional and Country Analysis

      10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Taxes Levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.8. Asia-Pacific Gene Therapy Market: Country Analysis

      11.9. China Market

      11.10. Summary

      11.11. Market Overview

      11.11.1. Country Information

      11.11.2. Market Information

      11.11.3. Background Information

      11.11.4. Government Initiatives

      11.11.5. Regulations

      11.11.6. Regulatory Bodies

      11.11.7. Major Associations

      11.11.8. Taxes Levied

      11.11.9. Corporate Tax Structure

      11.11.10. Investments

      11.11.11. Major Companies

      11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.17. India Market

      11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.23. Japan Market

      11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.29. Australia Market

      11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.35. Indonesia Market

      11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.40. South Korea Market

      11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.8. Western Europe Gene Therapy Market: Country Analysis

      12.9. UK Market

      12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.15. Germany Market

      12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.21. France Market

      12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.8. Eastern Europe Gene Therapy Market: Country Analysis

      13.9. Russia Market

      13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.8. North America Gene Therapy Market: Country Analysis

      14.9. USA Market

      14.10. Summary

      14.11. Market Overview

      14.11.1. Country Information

      14.11.2. Market Information

      14.11.3. Background Information

      14.11.4. Government Initiatives

      14.11.5. Regulations

      14.11.6. Regulatory Bodies

      14.11.7. Major Associations

      14.11.8. Taxes Levied

      14.11.9. Corporate Tax Structure

      14.11.10. Investments

      14.11.11. Major Companies

      14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.8. South America Gene Therapy Market: Country Analysis

      15.9. Brazil Market

      15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18. Competitive Landscape and Company Profiles

      18.1. Company Profiles

      18.2. Novartis AG

      18.2.1. Company Overview

      18.2.2. Products And Services

      18.2.3. Business Strategy

      18.2.4. Financial Overview

      18.3. F. Hoffmann-La Roche AG

      18.3.1. Company Overview

      18.3.2. Products And Services

      18.3.3. Business Strategy

      18.3.4. Financial Overview

      18.4. Gilead Sciences Inc.

      18.4.1. Company Overview

      18.4.2. Products And Services

      18.4.3. Financial Overview

      18.5. Astellas Pharma Inc.

      18.5.1. Company Overview

      18.5.2. Products And Services

      18.5.3. Business Strategy

      18.5.4. Financial Overview

      18.6. Biogen Inc.

      18.6.1. Company Overview

      18.6.2. Products And Services

      18.6.3. Business Strategy

      18.6.4. Financial Overview

      19. Key Mergers And Acquisitions

      19.1. Rocket Pharmaceuticals Acquired Renovacor

      19.2. Eli Lilly Acquired Akouos

      19.3. Ginkgo Bioworks Acquired Altar and Circularis

      19.4. Solvias Acquired Cergentis

      19.5. Novartis Acquired Gyroscope Therapeutics

      19.6. FHI Clinical Acquired Triclinium Clinical Development

      19.7. WuXi AppTec Acquired OXGENE

      20. Pipeline Analysis

      20.1. Products In Development

      20.2. Approved Products

      21. Opportunities And Strategies

      21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities

      21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities

      21.3. Global Gene Therapy Market In 2027 – Growth Strategies

      21.3.1. Market Trend Based Strategies

      21.3.2. Competitor Strategies

      22. Gene Therapy Market, Conclusions And Recommendations

      22.1. Conclusions

      22.2. Recommendations

      22.2.1. Product

      22.2.2. Place

      22.2.3. Price

      22.2.4. Promotion

      22.2.5. People

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. The Business Research Company

      23.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 4: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 5: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 6: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 7: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 8: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 9: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 10: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 11: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 14: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 15: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
    • Table 16:  Asia-Pacific Population, By Country, 2017-2027, Millions
    • Table 17: Asia-Pacific, Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 18: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 19: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 20: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 21: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 22: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 23: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 24: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 25: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 26: China GDP Per Capita, 2017-2022, $
    • Table 27:  China Population, 2017-2027, Millions
    • Table 28: China Pharmaceuticals Market Size, 2017-2027, $ Billion
    • Table 29: China Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 30: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 31: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 32: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 33: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 34: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 35: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 36: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 37: India Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 38: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 39: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 40: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 41: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 42: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 43: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 44: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 45: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 46: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 47: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 48: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 49: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 50: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 51: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 52: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 53: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 54: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 55: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 56: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 57: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 58: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 59: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 60: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 61: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 62: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 63: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 64: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 65: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 66: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 67: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 68: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 69: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 70: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 71: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 72: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 73: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 74: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 75: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 76: Western Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 77:  Western Europe Population, By Country, 2017-2027, Millions
    • Table 78: Western Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 79: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 80: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 81: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 82: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 83: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 84: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 85: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 86: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 87: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 88: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 89: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 90: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 91: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 92: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 93: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 94: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 95: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 96: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 97: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 98: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 99: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 100: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 101: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 102: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 103: France Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 104: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 105: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 106: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 107: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 108: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 109: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 110: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 111: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 112:  Eastern Europe Population, By Country, 2017-2027, Millions
    • Table 113: Eastern Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 114: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 115: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 116: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 117: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 118: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 119: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 120: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 121: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 122: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 123: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 124: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 125: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 126: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 127: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 128: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 129: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 130: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 131:  North America Population, By Country, 2017-2027, Millions
    • Table 132: North America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 133: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 134: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 135: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 136: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 137: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 138: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 139: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 140: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 141: USA GDP Per Capita, 2017-2022, $
    • Table 142:  USA Population, 2017-2027, Millions
    • Table 143: USA Pharmaceuticals Market Size, 2017-2027, $ Billion
    • Table 144: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 145: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 146: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 147: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 148: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 149: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 150: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 151: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 152: South America GDP Per Capita, By Country, 2017-2022, $
    • Table 153:  South America Population, By Country, 2017-2027, Millions
    • Table 154: South America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 155: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 156: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 157: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 158: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 159: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 160: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 161: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 162: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 163: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 164: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 165: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 166: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 167: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 168: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 169: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 170: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 171: Middle East GDP Per Capita, By Country, 2017-2022, $
    • Table 172:  Middle East Population, By Country, 2017-2027, Millions
    • Table 173: Middle East Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 174: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 175: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 176: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 177: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 178: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 179: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 180: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 181: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 182: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 183:  Africa Population, By Country, 2017-2027, Millions
    • Table 184: Africa Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 185: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Table 186: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 187: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 188: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 189: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 190: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 191: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 192: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 193: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 194:  Novartis – Financial Performance, 2017– 2021, $Billion
    • Table 195: Roche – Financial Performance, 2017– 2021, $Billion
    • Table 196: Gilead – Financial Performance, 2017– 2021, $Billion
    • Table 197: Astellas – Financial Performance, 2017– 2021, $Billion
    • Table 198: Biogen – Financial Performance, 2017– 2021, $Billion
    • Table 199: Global Gene Therapy Market, Pipeline Analysis
    • Table 200: Global Gene Therapy Market, Approved Products
    • Table 201: Global Gene Therapy Market Type Gain ($ Million), 2022 – 2027, By Country
    • Table 202: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Gene Therapy Type, 2022 – 2027
    • Table 203: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Vector, 2022 – 2027
    • Table 204: Global Gene Therapy Market Type Gain ($ Million), Segmentation By End Users, 2022 – 2027
    • Table 205: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Application, 2022 – 2027
    • Table 206: Gene Therapy - Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Gene Therapy Market Segmentation By Gene Therapy Type
    • Figure 3: Global Gene Therapy Market Segmentation By Vector
    • Figure 4: Global Gene Therapy Market Segmentation By End Users
    • Figure 5: Global Gene Therapy Market Segmentation By Application
    • Figure 6: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 7: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 8: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 9: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 10: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 11: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 14: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 15: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 16: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 17: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 18: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 19: China Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 20: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 21: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 22: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 23: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 24: India Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 25: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 26: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 27: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 28: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 29: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 30: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 31: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 32: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 33: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 34: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 35: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 36: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 37: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 38: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 39: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 40: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 41: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 42: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 43: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 44: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 45: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 46: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 47: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 48: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 49: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 50: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 51: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 52: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 53: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 54: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 55: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 56: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 57: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 58: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 59: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 60: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 61: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 62: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 63: France Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 64: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 65: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 66: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 67: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 68: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 69: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 70: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 71: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 72: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 73: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 74: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 75: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 76: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 77: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 78: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 79: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 80: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 81: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 82: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 83: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 84: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 85: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 86: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 87: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 88: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 89: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 90: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 91: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 92: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 93: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 94: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 95: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 96: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 97: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 98: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 99: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 100: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 101: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 102: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 103: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million
    • Figure 104: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 105: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 106: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 107: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 108: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 109: Novartis – Financial Performance, 2017– 2021, $Billion
    • Figure 110: Roche – Financial Performance, 2017– 2021, $Billion
    • Figure 111: Gilead – Financial Performance, 2017– 2021, $Billion
    • Figure 112: Astellas – Financial Performance, 2017– 2021, $Billion
    • Figure 113: Biogen – Financial Performance, $Billion
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
    View Report